Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents

D Suez; G Krivan; S Jolles; M Stein; S Gupta; K Paris; P.M. van Hagen; N Brodszki; W Engl; H Leibl; B McCoy; L Yel

doi:10.2217/imt-2019-0057

Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents

D Suez, G Krivan, S Jolles, M Stein, S Gupta, K Paris, P.M. van Hagen, N Brodszki, W Engl, H Leibl, B McCoy, L Yel

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1057-1065
Number of pages	9
Journal	Immunotherapy
Volume	11
Issue number	12
DOIs	https://doi.org/10.2217/imt-2019-0057
Publication status	Published - 2019

Access to Document

10.2217/imt-2019-0057

http://hdl.handle.net/1765/122236

Cite this

@article{9415827a8de548638319798ebeef7e5d,

title = "Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents",

author = "D Suez and G Krivan and S Jolles and M Stein and S Gupta and K Paris and {van Hagen}, P.M. and N Brodszki and W Engl and H Leibl and B McCoy and L Yel",

year = "2019",

doi = "10.2217/imt-2019-0057",

language = "Undefined/Unknown",

volume = "11",

pages = "1057--1065",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "Future Medicine Ltd.",

number = "12",

}

TY - JOUR

T1 - Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents

AU - Suez, D

AU - Krivan, G

AU - Jolles, S

AU - Stein, M

AU - Gupta, S

AU - Paris, K

AU - van Hagen, P.M.

AU - Brodszki, N

AU - Engl, W

AU - Leibl, H

AU - McCoy, B

AU - Yel, L

PY - 2019

Y1 - 2019

U2 - 10.2217/imt-2019-0057

DO - 10.2217/imt-2019-0057

M3 - Article

VL - 11

SP - 1057

EP - 1065

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 12

ER -